Filter
7632
Filtered Results: 7632
Text search:
number
of
patients
Featured
Recommendations
731
New Publications
1929
Language
Document type
No document type
4300
Studies & Reports
1174
Guidelines
1075
Manuals
385
Strategic & Response Plan
228
Fact sheets
168
Training Material
127
Situation Updates
98
Resource Platforms
24
Infographics
19
Online Courses
17
Brochures
15
Dashboards/Maps
1
Videos
1
Countries / Regions
India
433
Global
253
Kenya
212
South Africa
212
Sierra Leone
194
Liberia
178
Western and Central Europe
162
Ethiopia
152
Uganda
139
Nigeria
134
Africa
115
Malawi
114
Nepal
112
Latin America and the Carribbean
108
Tanzania
107
Zambia
97
Rwanda
96
Bangladesh
92
Myanmar / Burma
86
Ghana
85
Syria
82
Ukraine
79
Namibia
63
Philippines
57
Congo, Democratic Republic of
56
Eastern Europe
56
Russia
55
Guinea
54
Zimbabwe
48
West and Central Africa
48
South–East Asia Region
48
Lesotho
47
Cambodia
46
Mozambique
46
East and Southern Africa
45
Middle East and North Africa
44
Asia
43
South Sudan
41
Haiti
40
Germany
38
Indonesia
35
Senegal
34
Brazil
32
Botswana
31
Burkina Faso
30
Eastern Europe and Central Asia
29
Cameroon
27
Yemen
24
Benin
22
Eswatini/ Swaziland
21
Colombia
19
Venezuela
19
Pakistan
16
Western Pacific Region
16
USA
15
Madagascar
15
Mali
13
Central African Republic
13
Iraq
12
Afghanistan
12
Albania
12
Tajikistan
12
Thailand
11
Sudan
11
Peru
11
Georgia
11
Somalia
10
Lebanon
10
Sri Lanka
10
Jordan
9
Chile
9
Palestine
9
Southern Africa
9
Laos
9
Moldova
9
Vietnam
9
Côte d’Ivoire / Ivory Coast
8
Angola
8
Paraguay
8
North America
8
United Kingdom
8
China
7
North Macedonia
6
Bolivia
6
Armenia
6
Turkey
5
Chad
5
Argentina
5
Ecuador
5
Mexico
5
Kazakhstan
5
Jamaica
5
France
5
Guinea-Bissau
4
Togo
4
Gambia
4
Hungary
4
Bhutan
4
Poland
4
Kyrgyzstan
4
Spain
4
Saudi Arabia
3
Niger
3
Singapore
3
Papua New Guinea
3
Serbia
3
El Salvador
3
Greece
3
Libya
3
Canada
3
Timor Leste/ East Timor
3
Romania
3
Uzbekistan
3
Mauritius
3
Morocco
2
Egypt
2
Ireland
2
Switzerland
2
Burundi
2
Honduras
2
Guatemala
2
Other region
2
Bulgaria
2
Lithuania
2
Slovakia
2
Iran
2
Australia
2
Portugal
2
Malaysia
1
Mauritania
1
Austria
1
Nicaragua
1
Fiji
1
Solomon Islands
1
North Korea
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Estonia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Belarus
1
French Guyana
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2849
Clinical Guidelines
692
Public Health
421
Women & Child Health
297
Key Resources
234
Capacity Building
163
Pharmacy & Technologies
102
Annual Report MEDBOX
2
Toolboxes
COVID-19
848
Mental Health
613
HIV
603
TB
496
Ebola
315
Caregiver
257
Rapid Response
255
AMR
248
NTDs
220
Conflict
180
NCDs
175
Pharmacy
166
Disability
146
Refugee
123
Planetary Health
122
Global Health Education
76
Cholera
64
Natural Hazards
58
Zika
49
Specific Hazards
44
Health Financing Toolbox
41
Polio
38
Social Ethics
26
Typhoon
3
South Sudan
1
Health Financing
1
A century after its discovery, Chagas' disease still represents a major public health challenge in Latin America. Moreover, because of growing population movements, an increasing number ... cases of imported Chagas' disease have now been detected in non-endemic areas, such as North America and some European countries. This parasitic zoonosis, caused by Trypanosoma cruzi, is transmitted to humans by infected Triatominae insects, or occasionally by non-vectorial mechanisms, such as blood transfusion, mother to fetus, or oral ingestion of materials contaminated with parasites. Following the acute phase of the infection, untreated individuals enter a chronic phase that is initially asymptomatic or clinically unapparent. Usually, a few decades later, 40-50% of patients develop progressive cardiomyopathy and/or motility disturbances of the oesophagus and colon. In the last decades several interventions targeting primary, secondary and tertiary prevention of Chagas' disease have been attempted. While control of both vectorial and blood transfusion transmission of T cruzi (primary prevention) has been successful in many regions of Latin America, early detection and aetiological treatment of asymptomatic subjects with Chagas' disease (secondary prevention) have been largely underutilised. At the same time, in patients with established chronic disease, several pharmacological and non-pharmacological interventions are currently available and have been increasingly used with the intention of preventing or delaying complications of the disease (tertiary prevention). In this review we discuss in detail each of these issues.
INTRODUCTION: The COVID-19 pandemic has disrupted health systems around the world. The objectives of this study are to estimate the overall effect of the pandemic on essential health service use and...
Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing ... of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many challenges of antimicrobial resistance (AMR) which include increasing social and economic costs and rising patient mortality. Although considered a global threat, it is already an emerging local health concern which calls for an urgent collaboration among different sectors to provide solutions addressing this growing problem.
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatment of...
As care teams struggle to treat an increasing number of patients around the world, we have made the following Clinical Effectiveness COVID-19 resou...
A key component of elimination is to reduce the number
of unmanaged trachomatous trichiasis cases to less than
1 per 1,000 population in affected...
March 2020
The number of African Union Member States reporting COVID-
19 cases is increasing and there is a likelihood of community transmission....
March 2020
The number of African Union Member States reporting COVID-
19 cases is increasing and there is a likelihood of community transmissio...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use ... antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. The indicators in this manual will complement the existing WHO (1993) indicators of outpatient antimicrobial use suggested in How to Investigate Drug Use in Health Facilities (including percentage of encounters in which an antibiotic was prescribed and percentage of medicine costs spent on antibiotics) and will address the need for antimicrobial indicators for inpatient conditions.
The provision of safe and efficacious blood and blood components for transfusion or manufacturing use involves a number of processes, from the sele...
This an updated revised edition of the book which is published in 1986 ,The whole text has been updated and revised in line with current anaesthetic teaching. New chapters on hypothermia and acute pain relief added and some other chapters for easier...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation ... safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. Data from the WHO Global Database for Blood Safety (GDBS) brings out several inadequacies related to the supply and safety of blood and blood products. These inadequacies include a number of variations in safe blood practices across the world, including the quantity of blood donated (voluntary and replacement types), quality and adequate testing of the donated blood (immunohaematology [IH] and transfusion-transmitted infections [TTIs]), rational use of blood and blood components such as appropriate patient blood management protocols. These variations are very high in countries of the South-East Asian Region and most of them are either low- or middle-income countries (LMICs).
The guide is organized into the major types of toxicities, the associated symp-toms, possible offending medications, and the suggested nursing assessments and interventions. Some symptoms (e.g. nausea) may be associated with a ...-ber of underlying causes and may be mild, or a symptom of a more serious medical situation requiring urgent attention. The pathophysiology for medica-tion-related fatigue and hypersalivation are unclear and these symptoms are not grouped under a specific type of toxicity. Additional information (comments) are provided for each toxicity to highlight relevant clinical information that may assist in management of side effects. Medications more strongly associated with the side effect appear in bold text. The appendices include tools nurses can use to more thoroughly assess patient complaints of pain, depression and neuropathy.
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal ...
Antibiotics are among the most frequently prescribed classes of drugs and it is estimated that approximately 50% of antibiotic use, in both the outpatient and inpatient settings, is inappropriate. A...
Training Manual for Doctors.
Cardiac deaths are highest cause of death in Bangladesh. Trauma, burn, poisoning and snake bite are commonly encountered in the emergency room of a hospital. Road traff...
Background: Cervical cancer accounts for 23% of cancer incidence and 22% of cancer mortality among women in Burkina Faso. These proportions are more than 2 and 5 times higher than those ... developed countries, respectively. Before 2010, cervical cancer prevention (CECAP) services in Burkina Faso were limited to temporary screening campaigns.
Program Description: Between September 2010 and August 2014, program implementers collaborated with the Ministry of Health and professional associations to implement a CECAP program focused on coupling visual inspection with acetic acid (VIA) for screening with same-day cryotherapy treatment for eligible women in 14 facilities. Women with larger lesions or lesions suspect for cancer were referred for loop electrosurgical excision procedure (LEEP). The program trained providers, raised awareness through demand generation activities, and strengthened monitoring capacity.
Methods: Data on program activities, service provision, and programmatic lessons were analyzed. Three data collection tools, an individual client form, a client registry, and a monthly summary sheet, were used to track 3 key CECAP service indicators: number of women screened using VIA, proportion of women who screened VIA positive, and proportion of women screening VIA positive who received same-day cryotherapy.
Results: Over 4 years, the program screened 13,999 women for cervical cancer using VIA; 8.9% screened positive; and 65.9% received cryotherapy in a single visit. The proportion receiving cryotherapy on the same day started at a high of 82% to 93% when services were provided free of charge, but dropped to 51% when a user fee of $10 was applied to cover the cost of supplies. After reducing the fee to $4 in November 2012, the proportion increased again to 78%. Implementation challenges included difficulties tracking referred patients, stock-outs of key supplies, difficulties with machine maintenance, and prohibitive user fees. Providers were trained to independently monitor services, identify gaps, and take corrective actions.
Conclusions: Following dissemination of the results that demonstrated the acceptability and feasibility of the CECAP program, the Burkina Faso Ministry of Health included CECAP services in its minimum service delivery package in 2016. Essential components for such programs include provider training on VIA, cryotherapy, and LEEP; provider and patient demand generation; local equipment maintenance; consistent supply stocks; referral system for LEEP; non-prohibitive fees; and a monitoring data collection system.
Maternal mortality has fallen significantly in recent years, especially in countries that have emphasized the prevention of its main causes, such as hemorrhagic and infectious complications and hypertension , including in the Region ... the Americas. In its final report on the Plan of Action to Accelerate the Reduction of Maternal Mortality and Severe Maternal Morbidity, the Pan American Health Organization (PAHO) reported a continuing downward trend in maternal mortality, with an 18.1% reduction in the maternal morbidity ratio during the period 2010-2015 . From a pathophysiological perspective, death events are a common end result of a wide spectrum of complications leading to multi-organ dysfunction. However, there is a group of women in this situation who survive, despite the seriousness of their condition. This high number of patients––who were in serious condition
but did not die––reflects the actual health conditions in an institution or a country. For this reason, there is a need to create indicators to estimate morbidity in women due to diseases and incidents that occur during pregnancy, childbirth, and the puerperium. To this end, we propose conducting epidemiological surveillance of an indicator that includes women who survived after presenting a potentially fatal complication during pregnancy, childbirth, or the puerperium, reflecting quality medical attention and care (5, 6). This indicator
is maternal near-miss (MNM), which refers to extremely severe maternal morbidity––cases of a severity that
brings women very close to the death event. After adjusting the definition to a specific population and time,
MNM is defined as a case in which a woman nearly died, but survived a complication that occurred during
pregnancy, childbirth, or within 42 days of termination of pregnancy
Too few physicians are equipped with the knowledge and skills needed to repair genital fistulae and care for patients following surgery. Most procedures are performed in Africa and Asia by local physicians, with technical support from surgeons from ...
Website last accessed on 16.03.2024
GO developed our Cancer Education Materials (CEM) tool to improve the patient diagnosis and treatment experience in resource-limited settings, reduce stigma, help facilitate dialogue between ... and providers, and ensure that no patient stops treatment because they haven’t received complete information about the care process. These picture-based and culturally-appropriate materials were originally developed for a partner in Malawi, and the GO team continues its work to adapt, refine, evaluate, and expand our efforts, adding more languages and modes of treatment.
You can download “Cancer and You” in a number of languages including English, Spanish, Haitian Creole, Setswana, Luganda, Kiswahili, and Kinyarwanda.
